Adenosine Injection
Product Images NDC 51662-1631

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Adenosine (NDC 51662-1631). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Label (Serialized Labeling)

Label excerpt for ADENOSINE injection, showing a barcode and numeric identifiers including lot and expiration dates. Distributed by HF Acquisition Co., LLC, Mukilteo, WA. The image includes text instructing to see the manufacturer's package insert for more information.*

FDA Label Image

Structure (Structure)

Chemical structure of Adenosine showing its molecular formula C10H13N5O4 and molecular weight 267.25, depicted with detailed atom connectivity including nitrogen, oxygen, carbon, and hydrogen atoms.*

FDA Label Image

Vial Label (Vial Label)

Label for Adenosine Injection USP 6 mg/2 mL (3 mg/mL) single-dose vial by Mylan Institutional LLC. The label states it is sterile, nonpyrogenic, preservative-free, for rapid bolus intravenous use, and Rx only. The vial volume is 2 mL. Manufactured in India for Mylan Institutional LLC, Rockford, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.